Study to Determine the Prevalence of Homologous Recombination Deficiency Among Women With Newly Diagnosed, High-grade, Serous or Endometrioid Ovarian, Primary Peritoneal, and/or Fallopian Tube Cancer
Condition: Fallopian Tube Cancer Intervention: Sponsor: AstraZeneca Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Cancer | Cancer & Oncology | Endometrial Cancer | Fallopian Tube Cancer | Ovarian Cancer | Ovaries | Research | Study | Women